Movendo Technology

Movendo Technology operates at the intersection of medical devices, rehabilitation robotics and digital health. Its focus is on robotic assessment and rehabilitation for orthopedic, neurological and geriatric care, rather than on general-purpose industrial robotics or consumer fitness equipment. The product range spans robotic platforms—including hunova and huno—and assessment-oriented indices such as SILVER INDEX, PERFORMANCE INDEX and KNEE INDEX. The company describes hunova as a robotic physiotherapy assistant and emphasizes sensor-based exercises, movement monitoring and interactive feedback. Its stated technical foundation includes robotics and AI research associated with the Italian Institute of Technology, while ISO 13485 certification is a relevant quality-system credential for a medical-device business. The available company profile does not identify named competitor companies, so a direct competitor ranking or market-share comparison cannot be substantiated. Its reported categories include Health Care, Robotics, Fitness and Wellness, reflecting a specialized rehabilitation offering that bridges clinical practice and technology.

Movendo Technology’s trajectory, as reflected in the available milestones, begins with its 2016 founding in Genoa and an $11 million Venture Round announced on Jan 2, 2017, led by Sergio Dompé. The funding provided an early financing milestone, but no later rounds, amounts or valuation are recorded here. Product information points to a development focus on robotic rehabilitation and assessment: hunova addresses lower-limb and trunk function, while huno supports interactive exercises for the trunk, hip, knee and ankle. The company also lists three assessment indices, suggesting a portfolio that extends beyond hardware into structured measurement and treatment-support applications. The Sep 16, 2020 partnership announcement with EMSAR is another identifiable milestone, although the announcement information available here does not specify its commercial scope or outcomes. The company’s website describes its technology as drawing on more than a decade of robotics and AI research at the Italian Institute of Technology. Accordingly, the documented pattern supports a specialized product-building trajectory, but not a confident conclusion about current growth rate.